Natera, Inc.
NASDAQ:NTRA · NASDAQ Global Select
+$2.23 today
Vol 2.63M · Avg 1.41M
Cash Flow
Check whether earnings turn into cash
Use operating cash flow, capital spending, free cash flow, and financing activity to see how much value is left for reinvestment or owners.
Free Cash Flow
Net Income to FCF bridge
Analysis
Analysis will appear once cash flow data is available for this period.
Cash Flow Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$208.2M -9.3% | -$190.4M +56.2% | -$434.8M +20.6% | -$547.8M -16.1% | -$471.7M | $487.6M | $476.4M | $465.2M |
| Depreciation & Amortization | $43.5M +40.4% | $31.0M +28.5% | $24.1M +44.3% | $16.7M +48.4% | $11.3M | $374.2M | $1.2B | $631.8M |
| Deferred Income Tax | -$60.8M | $0 | $0 | $0 | $0 | $1.4B | -$1.5B | $304.2M |
| Stock-Based Compensation | $0 -100.0% | $274.4M +43.1% | $191.8M +25.9% | $152.4M +32.3% | $115.2M | $489.0M | $354.6M | -$1.6B |
| Change in Working Capital | $70.8M +3209.0% | $2.1M +104.5% | -$48.0M +42.3% | -$83.2M -82.3% | -$45.6M | $350.4M | -$1.6B | $1.5B |
| Accounts Receivables | $20.8M +157.8% | -$35.9M -5.8% | -$33.9M +72.3% | -$122.3M -181.1% | -$43.5M | $592.6M | $1.3B | $626.2M |
| Inventory | -$20.9M -423.7% | -$4.0M +25.6% | -$5.4M +37.0% | -$8.5M -23.5% | -$6.9M | $1.0B | $1.2B | $1.1B |
| Accounts Payables | $753.0K -94.3% | $13.2M +185.5% | -$15.5M -383.0% | $5.5M -71.6% | $19.2M | $948.2M | -$1.5B | $433.0M |
| Other Working Capital | $70.2M +143.9% | $28.8M +325.8% | $6.8M -84.0% | $42.2M +392.3% | -$14.4M | $567.4M | $1.3B | $601.0M |
| Other Non-Cash Items | $369.9M +1893.9% | $18.6M -6.7% | $19.9M -34.5% | $30.4M -45.4% | $55.6M | $1.4B | -$1.5B | $300.0M |
| Operating Cash Flow | $215.3M +58.7% | $135.7M +154.9% | -$247.0M +42.8% | -$431.5M -28.7% | -$335.2M | $7.2B | $8.9B | $10.5B |
| Capital Expenditures | -$106.2M -59.9% | -$66.4M -69.5% | -$39.2M +17.8% | -$47.7M -16.2% | -$41.0M | $664.0M | $1.4B | $697.6M |
| Acquisitions (Net) | -$16.0M | $0 | $0 | $0 | $0 | $937.0M | $1.1B | $1.3B |
| Purchases of Investments | $0 +100.0% | -$124.7M -26.8% | -$98.3M -13.1% | -$86.9M +90.1% | -$876.1M | $444.2M | $1.4B | $1.3B |
| Sales of Investments | $23.0M -93.2% | $339.2M +10.9% | $306.0M -34.2% | $465.0M -35.5% | $720.5M | $822.2M | $318.2M | -$1.5B |
| Other Investing Activities | $0 +100.0% | -$10.5M | $0 | $0 +100.0% | -$8.6M | $616.4M | $370.0M | $1.2B |
| Investing Cash Flow | -$132.2M -196.1% | $137.6M -18.3% | $168.5M -49.0% | $330.3M +261.0% | -$205.2M | $4.8B | $6.4B | $5.1B |
| Debt Repayment | $0 +100.0% | -$82.0K | $0 -100.0% | $30.0M | $0 | $680.8M | $759.2M | $1.1B |
| Common Stock Issued | $47.5M +56.7% | $30.3M -88.1% | $254.5M -43.8% | $452.6M -21.4% | $576.2M | $778.8M | $946.8M | $812.4M |
| Common Stock Repurchased | $0 | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $535.2M | $613.6M | $692.0M |
| Other Financing Activities | $0 | $0 | $0 | $0 | $0 | -$1.6B | $1.3B | $1.1B |
| Financing Cash Flow | $47.5M +57.1% | $30.2M -88.1% | $254.5M -47.3% | $482.6M -16.2% | $576.2M | $12.2B | $13.9B | -$15.5B |
| Effect of Forex Changes | $0 | $0 | $0 | $0 | $0 | $1.3B | $1.1B | $990.2M |
| Net Change in Cash | $130.6M -57.0% | $303.5M +72.4% | $176.0M -53.9% | $381.5M +966.8% | $35.8M | $3.2B | $4.9B | $6.5B |
| Free Cash Flow | $109.1M +57.6% | $69.2M +124.2% | -$286.2M +40.3% | -$479.2M -27.4% | -$376.3M | $8.6B | -$16.8B | $11.1B |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Teva Pharmaceutical Industries Limited
NYSE:TEVA
$36.61B
IQVIA Holdings Inc.
NYSE:IQV
$28.05B
DexCom, Inc.
NASDAQ:DXCM
$27.83B
Koninklijke Philips N.V.
NYSE:PHG
$26.02B
Illumina, Inc.
NASDAQ:ILMN
$24.53B
Waters Corporation
NYSE:WAT
$23.26B
Mettler-Toledo International Inc.
NYSE:MTD
$23.17B
BioNTech SE
NASDAQ:BNTX
$23.08B
Quest Diagnostics Incorporated
NYSE:DGX
$21.44B
STERIS plc
NYSE:STE
$19.70B
SEC Filings
Recent regulatory filings
No filings found.
Does NTRA generate free cash flow?
Natera, Inc. (NTRA) generated $109.11M of free cash flow in fiscal 2025.
How much operating cash flow does NTRA produce?
Operating cash flow was $215.30M, before capital expenditures of $106.19M.
Explore More
Continue the stock analysis
Jump to another research area for this company.